🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
Fat/Fatty Acid Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 430mg UL 3000mg

Other Ingredients

Gelatin Glycerin

Label Claims — Verification

Nutrient
All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Pregnant Women Adult Female (18 - 50 Years) Lactating

Product Information

📋 Directions for Use

DOSAGE AND ADMINISTRATION: Before, during and after pregnancy, one tablet and one softgel capsule taken by mouth daily, or as directed by a physician. The tablet and softgel may be taken together or at different times of the day.

⚠️ Warnings & Precautions

Softgel contains fish

As with any prescription strength product containing folic acid, omega fatty acids, iron or non-water soluble Vitamins D and E, adhere carefully to the dosages prescribed by your physician.

Folic acid may obscure the diagnosis of pernicious anemia. Supplementation with omega fatty acids should be avoided in patients with inherited or acquired bleeding diatheses, including those taking antiocoagulants.

🧪 Formulation Notes

Softgel contains fish

The daily regimen of PR(TM) Natal 430 contains: ~430 mg of omega-3 fatty acids - including at least 295 mg DHA. ~15 vitamins and minerals - including 1 mg folic acid. Softgel contains fish

PR Natal 430 With DHA

Additional Information

Rx Only

PRENATAL VITAMINS

See package insert for full product information.

Rev.2.0

See package insert for complete usage and safety data.

Product Details

DSLD Entry Date 2013-10-25
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 26072
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →